Frank J Vajda

Summary

Affiliation: St Vincent's Hospital
Country: Australia

Publications

  1. ncbi request reprint Neuroprotection and neurodegenerative disease
    Frank J E Vajda
    Australian Centre for Clinical Neuropharmacology, St Vincent s Hospital, Melbourne, Victoria, 3065, Australia
    J Clin Neurosci 9:4-8. 2002
  2. ncbi request reprint Letter to the neurology editor
    Frank J E Vajda
    J Clin Neurosci 12:210. 2005
  3. ncbi request reprint The Australian antiepileptic drug in pregnancy register: aspects of data collection and analysis
    Frank J E Vajda
    Monash University and Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
    J Clin Neurosci 14:936-42. 2007
  4. ncbi request reprint Maternal valproate dosage and foetal malformations
    F J E Vajda
    Raoul Wallenberg Centre, St Vincent s Hospital, Australian Centre for Clinical Neuropharmacology, University of Melbourne, Melbourne, Australia
    Acta Neurol Scand 112:137-43. 2005
  5. ncbi request reprint Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy
    Frank J Vajda
    Department of Medicine, The Australian Centre For Neuropharmacology, Raoul Wallenberg Centre, St Vincent s Hospital, Fitzroy, 3065 Melbourne, Vic, Australia
    J Clin Neurosci 11:854-8. 2004
  6. ncbi request reprint The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months
    Frank J Vajda
    Australian Centre for Neuropharmacology, Raoul Wallenberg Centre, St Vincent s Hospital, Melbourne, Australia
    J Clin Neurosci 10:543-9. 2003
  7. ncbi request reprint Epilepsy and porphyria: new perspectives
    Carlo Solinas
    Australian Centre for Clinical Neuropharmacology Raoul Wallenberg Centre, Centre for Clinical Neuroscience, St Vincent s Hospital, University of Melbourne, Vic, Australia
    J Clin Neurosci 11:356-61. 2004
  8. doi request reprint Dose dependence of fetal malformations associated with valproate
    Frank J Vajda
    From the Department of Medicine and Neuroscience F J V, T J O, J E G, University of Melbourne, Royal Melbourne Hospital, Parkville and University of Queensland C M L, M J E, Royal Brisbane Hospital, Brisbane, Australia
    Neurology 81:999-1003. 2013
  9. ncbi request reprint The internal control group in a register of antiepileptic drug use in pregnancy
    Frank J E Vajda
    Department of Medicine, Monash University and Medical Centre, 246 Clayton Road, Clayton, Victoria 3468, Australia
    J Clin Neurosci 15:29-35. 2008
  10. ncbi request reprint Seizure control in antiepileptic drug-treated pregnancy
    Frank J E Vajda
    Monash University and Medical Centre, Clayton, Victoria 3168, Australia
    Epilepsia 49:172-6. 2008

Detail Information

Publications15

  1. ncbi request reprint Neuroprotection and neurodegenerative disease
    Frank J E Vajda
    Australian Centre for Clinical Neuropharmacology, St Vincent s Hospital, Melbourne, Victoria, 3065, Australia
    J Clin Neurosci 9:4-8. 2002
    ..New drugs would also need to be shown to be safe and acceptable, physiologically not detrimental to humans and free from idiosyncratic adverse effects...
  2. ncbi request reprint Letter to the neurology editor
    Frank J E Vajda
    J Clin Neurosci 12:210. 2005
  3. ncbi request reprint The Australian antiepileptic drug in pregnancy register: aspects of data collection and analysis
    Frank J E Vajda
    Monash University and Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
    J Clin Neurosci 14:936-42. 2007
    ..It is desirable to have available such analyses of pregnancy register data before comparing the findings of different registers...
  4. ncbi request reprint Maternal valproate dosage and foetal malformations
    F J E Vajda
    Raoul Wallenberg Centre, St Vincent s Hospital, Australian Centre for Clinical Neuropharmacology, University of Melbourne, Melbourne, Australia
    Acta Neurol Scand 112:137-43. 2005
    ....
  5. ncbi request reprint Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy
    Frank J Vajda
    Department of Medicine, The Australian Centre For Neuropharmacology, Raoul Wallenberg Centre, St Vincent s Hospital, Fitzroy, 3065 Melbourne, Vic, Australia
    J Clin Neurosci 11:854-8. 2004
    ..A prospective, observational, community-based cohort study...
  6. ncbi request reprint The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months
    Frank J Vajda
    Australian Centre for Neuropharmacology, Raoul Wallenberg Centre, St Vincent s Hospital, Melbourne, Australia
    J Clin Neurosci 10:543-9. 2003
    ..It is uncertain how much of this risk is directly caused by the AEDs and whether certain drugs or combinations are associated with a greater risk...
  7. ncbi request reprint Epilepsy and porphyria: new perspectives
    Carlo Solinas
    Australian Centre for Clinical Neuropharmacology Raoul Wallenberg Centre, Centre for Clinical Neuroscience, St Vincent s Hospital, University of Melbourne, Vic, Australia
    J Clin Neurosci 11:356-61. 2004
    ..Application of neuroimaging may detect epileptogenic foci, helping to define the specific risk of seizures for each patient...
  8. doi request reprint Dose dependence of fetal malformations associated with valproate
    Frank J Vajda
    From the Department of Medicine and Neuroscience F J V, T J O, J E G, University of Melbourne, Royal Melbourne Hospital, Parkville and University of Queensland C M L, M J E, Royal Brisbane Hospital, Brisbane, Australia
    Neurology 81:999-1003. 2013
    ..To study the relationships between maternal valproate dose in pregnancy and the pattern of various fetal malformations...
  9. ncbi request reprint The internal control group in a register of antiepileptic drug use in pregnancy
    Frank J E Vajda
    Department of Medicine, Monash University and Medical Centre, 246 Clayton Road, Clayton, Victoria 3468, Australia
    J Clin Neurosci 15:29-35. 2008
    ....
  10. ncbi request reprint Seizure control in antiepileptic drug-treated pregnancy
    Frank J E Vajda
    Monash University and Medical Centre, Clayton, Victoria 3168, Australia
    Epilepsia 49:172-6. 2008
    ..Once there had been 1 year's freedom from seizures there seemed relatively little further advantage in deferring pregnancy to avoid seizures returning while pregnant...
  11. ncbi request reprint The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies
    Frank J E Vajda
    Department of Medicine, Monash University and Medical Centre, Clayton, Victoria, Australia
    Aust N Z J Obstet Gynaecol 47:468-74. 2007
    ..Prospective studies are needed to assess the maternal and fetal hazards of antiepileptic drug (AED) therapy in pregnancy...
  12. ncbi request reprint Monitoring antiepileptic drug therapy with serum level measurements
    Frank J E Vajda
    Monash Medical Centre, Monash University, Melbourne, Vic, Australia
    Med J Aust 187:581. 2007
  13. ncbi request reprint Pharmacotherapy of epilepsy: new armamentarium, new issues
    Frank J E Vajda
    Department of Medicine, Monash University and Medical Centre, 246 Clayton Road, Clayton 3168, Victoria, and Department of Medicine, St Vincents Hospital, Melbourne, Australia
    J Clin Neurosci 14:813-23. 2007
    ..With improvement in diagnostic techniques and new therapeutic modalities it is likely that in the future, pharmacogenomics and an understanding of pharmacoresistance may influence drug selection for individual patients with epilepsy...
  14. ncbi request reprint Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study
    Roy G Beran
    Strategic Health Evaluators and University of New South Wales, 12 Thomas Street, Suite 5, 6th Floor, Chatswood, NSW 2067, Australia
    Epilepsy Res 63:1-9. 2005
    ..To evaluate the efficacy and tolerability of levetiracetam as add-on therapy in patients with refractory partial-onset seizures in a protocol designed to reflect clinical practice...
  15. ncbi request reprint The influence of gender on the aggravation of absence seizures by carbamazepine in the low-dose pentylenetetrazol rat model
    Karen J McLean
    Australian Centre for Clinical Neuropharmacology, Raoul Wallenerg Centre, Melbourne, Vic, Australia
    Seizure 13:208-16. 2004
    ..To determine whether carbamazepine (CBZ) aggravates absence seizures in the low-dose pentylenetetrazol (PTZ) rat model in both male and female animals, and investigate for gender differences...